Xenon Pharmaceuticals Inc (XENE) — Cash Flow Reinvestment Rate
Xenon Pharmaceuticals Inc (XENE) has a Cash Flow Reinvestment Rate of 3.05x as of December 2019, reinvesting $60.27 Million (capex $595.00K plus investments $-59.67 Million) from operating cash flow of $19.73 Million. Check Xenon Pharmaceuticals Inc (XENE) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Xenon Pharmaceuticals Inc Cash Flow Reinvestment Rate (2012–2014)
Historical reinvestment intensity for Xenon Pharmaceuticals Inc across 2 annual periods. Explore investment intensity of Xenon Pharmaceuticals Inc to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Xenon Pharmaceuticals Inc (2012–2014)
Year-by-year capital reinvestment analysis for Xenon Pharmaceuticals Inc. For live market cap and broader valuation context, see XENE market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2014 | 12.20x | $3.24 Million | $266.00K | $1.53 Million | ▲ +105562.5% |
| 2012 | 0.01x | $526.00K | $45.57 Million | $526.00K | — |